Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

HCV coinfection adds to cardiovascular risk in HIV-infected patients

Key clinical point: Infections add to the risk of a cardiovascular disease event in HIV-infected individuals.

Major finding: HCV coinfection increased the risk of developing a CVD event in the HIV-infected patients (OR, 2.84).

Study details: A retrospective study of 823 patients at a single institution.

Disclosures: The authors reported that they had no conflicts.


Genebat M. et al. Antiviral Res. 2019 Sep;169:104527.